Partner Stuart Fross was quoted in a Board IQ article, “Pru Proposal: You Raise 12b-1 Fees, We’ll Lower Advisory Fee,” on May 19, 2015. The article discussed Prudential’s relatively uncommon request of shareholders in its Advanced Series Trust to approve a 15-basis-point increase in 12-b1 fees. Fross said the plan provides more clarity about what money is being used to pay for and was quoted saying, “It’s highly unusual in this day and age for an adviser to say, ‘I’m not comfortable with that. I want to have these payments made under 12b-1.’ The brokers don’t care [where the money comes from].”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”